Novo Nordisk faces $1.8 billion lawsuit over US insulin salesNovo Nordisk is facing a lawsuit from disgruntled investors seeking around $1.8 billion in compensation, saying the company Share XNovo Nordisk faces $1.8 billion lawsuit over US insulin saleshttps://pharmaphorum.com/news/novo-nordisk-faces-1-8-billion-lawsuit-over-us-insulin-sales/
Facing opioid liability risk, Mallinckrodt stalls generics splitMallinckrodt has put plans to separate its specialty generics business on hold while it gauges the impact of Share XFacing opioid liability risk, Mallinckrodt stalls generics splithttps://pharmaphorum.com/news/facing-opioid-liability-risk-mallinckrodt-stalls-generics-split/
German court blocks Sanofi’s cholesterol drug after Amgen lawsuitAmgen has lived up to its litigious reputation after it successfully persuaded a German court to uphold a Share XGerman court blocks Sanofi’s cholesterol drug after Amgen lawsuithttps://pharmaphorum.com/news/german-court-blocks-sanofis-cholesterol-drug-after-amgen-lawsuit/
Gilead faces lawsuit over HIV drug pricingGilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving Share XGilead faces lawsuit over HIV drug pricinghttps://pharmaphorum.com/news/gilead-faces-lawsuit-over-hiv-drug-pricing/
Teva vows to fight price-fixing lawsuitTeva has said it will defend itself against a lawsuit raised by 44 US states that alleges the Share XTeva vows to fight price-fixing lawsuithttps://pharmaphorum.com/news/teva-vows-to-fight-price-fixing-lawsuit/
Drug firm prosecuted for distributing opioids illegallyA US-based drug distribution company and two former executives are being prosecuted for transporting medicines to pharmacies allegedly Share XDrug firm prosecuted for distributing opioids illegallyhttps://pharmaphorum.com/news/drug-firm-prosecuted-for-distributing-opioids-illegally/
Bayer and J&J settle Xarelto lawsuits in USBayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 Share XBayer and J&J settle Xarelto lawsuits in UShttps://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/
Celgene gets US patent let-off ahead of BMS mergerShares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on Share XCelgene gets US patent let-off ahead of BMS mergerhttps://pharmaphorum.com/news/celgene-gets-us-patent-let-off-ahead-of-bms-merger/
Documentaries lift lid on Theranos biotech scamAs criminal fraud investigations continue into former Theranos CEO Elizabeth Holmes and president Ramesh Balwani, further details are Share XDocumentaries lift lid on Theranos biotech scamhttps://pharmaphorum.com/news/documentaries-lift-lid-on-theranos-biotech-scam/
